Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)
China · Delayed Price · Currency is CNY 27.16
-0.54 (-1.95%)
Jun 11, 2026, 1:25 PM CST
SHE:301111 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -4.35 | -4.49 | 4.16 | 33.5 | 33.42 | 57.18 |
Depreciation & Amortization | 17.55 | 17.55 | 18.04 | 13.3 | 12.22 | 14.86 |
Other Amortization | 3.98 | 3.98 | 1.13 | 0.05 | - | - |
Loss (Gain) From Sale of Assets | - | - | - | - | 0.33 | 0.01 |
Asset Writedown & Restructuring Costs | 0 | 0 | 1.02 | 3.8 | 8.4 | 6.7 |
Loss (Gain) From Sale of Investments | -12.89 | -12.89 | -10.19 | -12.03 | -14.97 | -2.42 |
Provision & Write-off of Bad Debts | 0.04 | 0.04 | -1.62 | 1.26 | 0 | - |
Other Operating Activities | 7.61 | 0.85 | 4.36 | 0.2 | -0.61 | -2.78 |
Change in Accounts Receivable | -38 | -38 | -30.6 | -3.19 | 24.37 | -14.06 |
Change in Inventory | 8.7 | 8.7 | -11.32 | -15.35 | -18.98 | 3.03 |
Change in Accounts Payable | 34.73 | 34.73 | 33.65 | -34.35 | 35.08 | 10.03 |
Change in Other Net Operating Assets | - | - | - | - | -0.42 | 0.56 |
Operating Cash Flow | 17.47 | 10.58 | 3.21 | -12.8 | 69.88 | 71.63 |
Operating Cash Flow Growth | - | 229.69% | - | - | -2.44% | -21.21% |
Capital Expenditures | -10.92 | -9.78 | -37.9 | -38.61 | -5.54 | -3.09 |
Sale of Property, Plant & Equipment | 1.22 | 0.6 | - | - | 0.15 | 0.01 |
Cash Acquisitions | -9.94 | -0.5 | -5.1 | - | - | - |
Divestitures | 13.57 | 13.57 | - | - | - | - |
Investment in Securities | 5.45 | -35.05 | 97.1 | 13.03 | -315 | -76.03 |
Other Investing Activities | 10.75 | 10 | 18.03 | 6.28 | 15.73 | 2.26 |
Investing Cash Flow | 10.13 | -21.14 | 72.13 | -19.3 | -304.67 | -76.86 |
Long-Term Debt Repaid | - | -3.06 | -2.19 | -1.09 | -0.96 | -0.84 |
Total Debt Repaid | -3.06 | -3.06 | -2.19 | -1.09 | -0.96 | -0.84 |
Net Debt Issued (Repaid) | -3.06 | -3.06 | -2.19 | -1.09 | -0.96 | -0.84 |
Issuance of Common Stock | - | - | - | - | - | 386.72 |
Common Dividends Paid | -8 | -8 | -16 | -16 | -25.6 | - |
Other Financing Activities | 7.44 | 5.17 | 3.4 | - | -9.2 | -6.82 |
Financing Cash Flow | -8.19 | -5.89 | -14.79 | -17.09 | -35.76 | 379.06 |
Net Cash Flow | 19.42 | -16.46 | 60.55 | -49.19 | -270.55 | 373.83 |
Free Cash Flow | 6.55 | 0.8 | -34.69 | -51.41 | 64.34 | 68.54 |
Free Cash Flow Growth | - | - | - | - | -6.13% | 52.97% |
Free Cash Flow Margin | 2.11% | 0.26% | -12.45% | -17.58% | 22.71% | 19.59% |
Free Cash Flow Per Share | 0.04 | 0.01 | -0.25 | -0.32 | 0.40 | 0.57 |
Cash Income Tax Paid | 14.12 | 17.04 | 15.72 | 47.82 | 31.51 | 38.9 |
Levered Free Cash Flow | -281.7 | -256.39 | -21.02 | -56.42 | 55.19 | 60.76 |
Unlevered Free Cash Flow | -279.95 | -254.47 | -19.48 | -56.19 | 55.21 | 60.8 |
Change in Working Capital | 5.53 | 5.53 | -13.68 | -52.87 | 31.09 | -1.92 |